Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chrysi Koliaki

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Advances in Therapy|November 28, 2012
Linagliptin/Metformin fixed-dose combination treatment: a dual attack to type 2 diabetes pathophysiologyChrysi Koliaki, John Doupis
Nutrition Reviews|June 5, 2013
Dietary sodium, potassium, and alcohol: key players in the pathophysiology, prevention, and treatment of human hypertensionChrysi Koliaki, Nicholas Katsilambros
Molecular and Cellular Endocrinology|June 18, 2013
Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver diseaseChrysi Koliaki, Michael Roden
International Journal of Molecular Sciences|March 25, 2022
Repositioning the Role of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) on the TRAIL to the Development of Diabetes Mellitus: An Update of Experimental and Clinical EvidenceChrysi Koliaki, Nicholas Katsilambros
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 1, 2011
Incretin-based therapy: a powerful and promising weapon in the treatment of type 2 diabetes mellitusChrysi Koliaki, John Doupis
International Journal of Environmental Research and Public Health|December 28, 2019
Important Considerations for the Treatment of Patients with Diabetes Mellitus and Heart Failure from a Diabetologist's Perspective: Lessons Learned from Cardiovascular Outcome TrialsChrysi Koliaki, Nicholas Katsilambros
Annual Review of Nutrition|May 6, 2016
Alterations of Mitochondrial Function and Insulin Sensitivity in Human Obesity and Diabetes MellitusChrysi Koliaki, Michael Roden
Biomedicines|July 29, 2023
Novel Dual Incretin Receptor Agonists in the Spectrum of Metabolic Diseases with a Focus on Tirzepatide: Real Game-Changers or Great Expectations? A Narrative ReviewAlexandros Leonidas Liarakos, Chrysi Koliaki
Metabolism: Clinical and Experimental|November 7, 2018
Obesity and cardiovascular disease: revisiting an old relationshipChrysi Koliaki, Stavros Liatis, Alexander Kokkinos
International Journal of Environmental Research and Public Health|September 5, 2019
Remission of Type 2 Diabetes Mellitus after Bariatric Surgery: Fact or Fiction?Dimitrios Tsilingiris, Chrysi Koliaki, Alexander Kokkinos
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Advances in Therapy|November 28, 2012
Linagliptin/Metformin fixed-dose combination treatment: a dual attack to type 2 diabetes pathophysiologyChrysi Koliaki, John Doupis
Nutrition Reviews|June 5, 2013
Dietary sodium, potassium, and alcohol: key players in the pathophysiology, prevention, and treatment of human hypertensionChrysi Koliaki, Nicholas Katsilambros
Molecular and Cellular Endocrinology|June 18, 2013
Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver diseaseChrysi Koliaki, Michael Roden
International Journal of Molecular Sciences|March 25, 2022
Repositioning the Role of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) on the TRAIL to the Development of Diabetes Mellitus: An Update of Experimental and Clinical EvidenceChrysi Koliaki, Nicholas Katsilambros
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 1, 2011
Incretin-based therapy: a powerful and promising weapon in the treatment of type 2 diabetes mellitusChrysi Koliaki, John Doupis
International Journal of Environmental Research and Public Health|December 28, 2019
Important Considerations for the Treatment of Patients with Diabetes Mellitus and Heart Failure from a Diabetologist's Perspective: Lessons Learned from Cardiovascular Outcome TrialsChrysi Koliaki, Nicholas Katsilambros
Annual Review of Nutrition|May 6, 2016
Alterations of Mitochondrial Function and Insulin Sensitivity in Human Obesity and Diabetes MellitusChrysi Koliaki, Michael Roden
Biomedicines|July 29, 2023
Novel Dual Incretin Receptor Agonists in the Spectrum of Metabolic Diseases with a Focus on Tirzepatide: Real Game-Changers or Great Expectations? A Narrative ReviewAlexandros Leonidas Liarakos, Chrysi Koliaki
Metabolism: Clinical and Experimental|November 7, 2018
Obesity and cardiovascular disease: revisiting an old relationshipChrysi Koliaki, Stavros Liatis, Alexander Kokkinos
International Journal of Environmental Research and Public Health|September 5, 2019
Remission of Type 2 Diabetes Mellitus after Bariatric Surgery: Fact or Fiction?Dimitrios Tsilingiris, Chrysi Koliaki, Alexander Kokkinos
Pageof 5